EYES News and Press, Second Sight Medical Products Inc. From 03/26/21

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it has close...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Second Sight (NASDAQ: EYES ) agreed to issue new shares that would give 60% control to its competitor in France, Pixium Vision , on Jan. 6. Since then, EYES stock has risen. As a result, I suspect that management i...

Wah Fu Education Group (WAFU) +82%.180 Life Sciences (ATNF) +49%.NextDecade Corporation (NEXT) +31% on signing term sheet with Occidental Petroleum.Four Seasons Education (Cayman) (FEDU) +26%.Banco Santander Mexico SA ADR (BSMX) +19%.China Liberal Education Holdings Limited (CLEU) +18%.L...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips News of it obtaining regulatory approval for its flagship product has sent Second Sight (NASDAQ: EYES ) stock to the moon. Where’s this retinal health play headed from here? That’s the question on the ...

Gainers: Aptose Biosciences (APTO) +65%, Brainstorm Cell Therapeutics (BCLI) +13%, Prothena (PRTA) +12%, Armata Pharmaceuticals (ARMP) +8%, Inventiva (IVA) +8%.Losers: Benitec Biopharma (BNTC) -24%, Second Sight Medical Products (EYES) -1...

Benitec Biopharma (BNTC) -21%.Second Sight Medical Products (EYES) -21% on $28M capital raise.Takung Art (TKAT) -17%.Evolve Transition Infrastructure (SNMP) -15%.GameStop (GME) -14% on Q4 earnings release.CASI Pharmaceuticals (CASI) -12% after proposes stock offering....

Second Sight Medical Products (EYES) inks securities agreements with accredited investors, for the purchase of 4.65M common shares at $6.00, for gross proceeds of $27.9M, in a private placement.Net proceeds will be used for working capital.Closing date is March 26.EYES shares down 14% pr...

Second Sight Medical Products, Inc. (NASDAQ: EYES), (the "Company" or "Second Sight"), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it has entered into defin...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unquestionably, our most precious sense is our vision. I’m not disparaging the others but our sense of sight is what allows us to function and operate the best in this high-paced society. Sadly, myriad conditions tak...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s hard to not root for visual aid developer Second Sight Medical Products  (NASDAQ: EYES ), as the company works diligently to offer hope and solutions to those suffering from visual impairments. However...